These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 16100155

  • 1. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
    Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC.
    Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
    [Abstract] [Full Text] [Related]

  • 2. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
    Hua CC, Chang LC, Chen YC, Chang SC.
    Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
    [Abstract] [Full Text] [Related]

  • 3. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C, Alegre J, Monasterio J, Segura RM, Armadans L, Anglés A, Varela E, Ruiz E, Fernández de Sevilla T.
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [Abstract] [Full Text] [Related]

  • 4. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
    Chung CL, Yeh CY, Sheu JR, Chen YC, Chang SC.
    Am J Med Sci; 2007 Dec; 334(6):452-7. PubMed ID: 18091367
    [Abstract] [Full Text] [Related]

  • 5. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions.
    Chiu CY, Wong KS, Huang JL, Tasi MH, Lin TY, Hsieh SY.
    Pediatr Infect Dis J; 2008 Aug; 27(8):699-703. PubMed ID: 18664985
    [Abstract] [Full Text] [Related]

  • 6. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
    Lin FC, Chen YC, Chen FJ, Chang SC.
    Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
    [Abstract] [Full Text] [Related]

  • 7. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.
    Chung CL, Hsiao SH, Hsiao G, Sheu JR, Chen WL, Chang SC.
    PLoS One; 2013 Aug; 8(1):e53169. PubMed ID: 23308155
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC, Corhay JL, Hubin L, Nguyen D, Henket M, Louis R.
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [Abstract] [Full Text] [Related]

  • 9. [Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells].
    Min R, Li S, Wang H, Zhang J, Wang T, Yang Y.
    Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):599-602. PubMed ID: 11798526
    [Abstract] [Full Text] [Related]

  • 10. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.
    Chung CL, Chen YC, Chang SC.
    Chest; 2003 Apr; 123(4):1188-95. PubMed ID: 12684310
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of cytokine measurement in pleural effusion].
    Naito T, Ohtsuka M, Ishikawa H, Satoh H, Hasegawa S.
    Kekkaku; 1997 Oct; 72(10):565-72. PubMed ID: 9386355
    [Abstract] [Full Text] [Related]

  • 12. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
    Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR.
    Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Cytokine Levers in Pleural Effusions of Tuberculous Pleurisy and Tuberculous Empyema.
    Yang L, Hu YJ, Li FG, Chang XJ, Zhang TH, Wang ZT.
    Mediators Inflamm; 2016 Oct; 2016():3068103. PubMed ID: 27034588
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study.
    Shojaee S, Voelkel N, Farkas L, de Wit M, Lee HJ.
    J Bronchology Interv Pulmonol; 2013 Oct; 20(4):304-8. PubMed ID: 24162112
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
    Alexandrakis MG, Coulocheri SA, Bouros D, Eliopoulos GD.
    Anticancer Res; 1999 Oct; 19(4C):3607-12. PubMed ID: 10629659
    [Abstract] [Full Text] [Related]

  • 16. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta).
    Tietze L, Elbrecht A, Schauerte C, Klosterhalfen B, Amo-Takyi B, Gehlen J, Winkeltau G, Mittermayer C, Handt S.
    Thromb Haemost; 1998 Feb; 79(2):362-70. PubMed ID: 9493592
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
    Momi H, Matsuyama W, Inoue K, Kawabata M, Arimura K, Fukunaga H, Osame M.
    Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
    [Abstract] [Full Text] [Related]

  • 18. Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions.
    Marchi E, Vargas FS, Acencio MM, Sigrist RMS, Biscaro MDA, Antonangelo L, Teixeira LR, Light RW.
    Chest; 2012 Jan; 141(1):183-189. PubMed ID: 21680642
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions.
    Xirouchaki N, Tzanakis N, Bouros D, Kyriakou D, Karkavitsas N, Alexandrakis M, Siafakas NM.
    Chest; 2002 Mar; 121(3):815-20. PubMed ID: 11888965
    [Abstract] [Full Text] [Related]

  • 20. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, Gourgoulianis KI.
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.